Thailand Plans to Begin Human Trials for Covid-19 Vaccine in the Upcoming Months​

Thailand will start clinical trials for the Covid-19 vaccine on humans after their findings showed that monkeys and mice could produce antibodies against the virus after injected with Cu-Cov19, an mRNA vaccine.

“We hope that the vaccine could generate neutralizing antibodies in humans seen in monkeys and mice,” said Kiat Ruxrungtham, head researcher at Chulalongkorn University’s Center of Excellence in Vaccine Research and Development.

If the result is as expected, then they will be able to produce millions of vaccines for its people by late next year.

According to the World Health Organization, there are 160 vaccines worldwide, but 21 of them are at the clinical evaluation stage. Thailand will be the first, besides high-income countries to do this testing. Many countries are on the race to finding vaccines for the coronavirus virus which currently caused a total of over 13 million cases worldwide with the US having about 3.5 million confirmed cases. In Thailand, there are over 3,200 confirmed cases.

Thailand plans to do three phases of vaccine testing. In the first stage, they will recruit 100 volunteers with one group aged between 18 to 60 and another group between 60 and 80. They plan to start the first stage in September. In the second phase, they plan to use between 500 and 1000 volunteers, which is scheduled to start in December. In the third stage, the vaccine will be used for 10,000 volunteers in countries where there are outbreaks.


By: Noeut Sokhoeun